TRANSREPLIZIERENDE RNS
European patent · EP3433368 · In force
Register entry
- Publication number
- EP3433368
- Application number
- EP17710268
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Mar 13, 2017
- Published
- Jan 30, 2019
- Granted
- Oct 6, 2021
- Protection ends at the latest
- Mar 12, 2037
- Next annual fee due
- Mar 31, 2027
- IPC classes
- C12N 15/86 (2006.01)C12N 15/40 (2006.01)C12N 5/10 (2006.01)A61K 48/00 (2006.01)
- Priority
- WO PCT/EP2016/056160 21.03.2016
- PCT application
- PCT/EP2017/055813 13.03.2017
- PCT publication
- WO2017/162461 28.09.2017
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 1, 2026
Change
Published in Swissreg on 01.04.2026
- Apr 1, 2025
Change
Published in Swissreg on 01.04.2025
- Apr 1, 2024
Change
Published in Swissreg on 01.04.2024
- Apr 1, 2023
Change
Published in Swissreg on 01.04.2023
- Aug 17, 2022
Change
Published in Swissreg on 17.08.2022
- Nov 4, 2021
Agent entered
- Representative
- MICHELI & CIE SA, 122, rue de Genève,, CP 61, 1226 Thônex
Published in Swissreg on 04.11.2021
- Oct 6, 2021
Granted
Published in Swissreg on 06.10.2021
Parties
Holder
An der Goldgrube 12, 55131 Mainz, DE
TRON - Translationale Onkologie an der Universitätsmedizin der Johannes Gutenberg- Universität Mainz gemeinnützige GmbH
Freiligrathstrasse 12, 55131 Mainz, DE
Inventor
60437 Frankfurt, DE
55116 Mainz, DE
64521 Gross-Gerau, DE
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.